This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells’ transportation ...

lenacapavir or LEN), a twice-a-year injection that stops HIV from replicating inside cells, thereby reducing the risk of transmitting the virus to other people by 96%. HIV advocates hope it will ...